Dröge, E.; Probstmeier, R.; Wenghoefer, M.; Winter, J.
Occurrence of Human Defensins and S100 Proteins in Head and Neck Basal Cell Carcinoma (BCC) Entities: hBD3 and S100A4 as Potential Biomarkers to Evaluate Successful Surgical Therapy. J. Otorhinolaryngol. Hear. Balance Med. 2023, 4, 1.
https://doi.org/10.3390/ohbm4010001
AMA Style
Dröge E, Probstmeier R, Wenghoefer M, Winter J.
Occurrence of Human Defensins and S100 Proteins in Head and Neck Basal Cell Carcinoma (BCC) Entities: hBD3 and S100A4 as Potential Biomarkers to Evaluate Successful Surgical Therapy. Journal of Otorhinolaryngology, Hearing and Balance Medicine. 2023; 4(1):1.
https://doi.org/10.3390/ohbm4010001
Chicago/Turabian Style
Dröge, Eva, Rainer Probstmeier, Matthias Wenghoefer, and Jochen Winter.
2023. "Occurrence of Human Defensins and S100 Proteins in Head and Neck Basal Cell Carcinoma (BCC) Entities: hBD3 and S100A4 as Potential Biomarkers to Evaluate Successful Surgical Therapy" Journal of Otorhinolaryngology, Hearing and Balance Medicine 4, no. 1: 1.
https://doi.org/10.3390/ohbm4010001
APA Style
Dröge, E., Probstmeier, R., Wenghoefer, M., & Winter, J.
(2023). Occurrence of Human Defensins and S100 Proteins in Head and Neck Basal Cell Carcinoma (BCC) Entities: hBD3 and S100A4 as Potential Biomarkers to Evaluate Successful Surgical Therapy. Journal of Otorhinolaryngology, Hearing and Balance Medicine, 4(1), 1.
https://doi.org/10.3390/ohbm4010001
